TISSUE FACTOR IN CIRRHOTIC AND HEPATOCELLULAR CARCINOMA PATIENTS

FIBRINOLYTIC ACTIVITY IN HEPATOCELLULAR CARCINOMA

EVALUATION OF PROCOAGULANT POTENTIAL OF ENDOTHELIAL MICROPARTICLES CD144 IN DIABETIC AND NON-DIABETIC ACUTE CORONARY SYNDROME PATIENTS.

Evaluation of 4 Ts Score of Heparin Induced Thrombocytopenia as Predictive Value in Acute Lower Limb Ischemia Patients

UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR, PLASMINOGEN ACTIVATOR INHIBITOR- 1,EXTRACELLULAR MATRIX METALLOPROTEINASE PROTEIN INDUCER AND CA 15-3ASPOTENTIAL BIOMARKERS FOR DIAGNOSIS

Evaluation of Hemostaitc Parameters of Sudanese patients with liver Disease attending Khartoum Teaching Hospital

Study of the pathophysiologic role of tissue factorpathway inhibitor in modulating thalassemia induced hypercoagulable state:relationship to oxidative stress

Plasma Factor VII and Histidine-Rich Glycoprotein as A Potential Markers in Pre Eclampsia

Evaluation of plasma fibrinogen and plasminogen activator inhibitor- 1 in type 2 diabetes mellitus patients with coronary artery disease

EVALUATION OF MATERNAL PLACENTAL GROWTH FACTOR IN SUSPECTED PRE-ECLAMPTIC WOMEN